A little less than three years after New York investors paid $10.45 million for Cigna’s former global headquarters in Bloomfield, the new owners are considering offers for the massive complex.

Trees are the focal points of any home landscape. They can be towering old oaks that lend legitimacy and shade or small, new trees that bring color, life and animals into your yard. But no matter what ...

Phoenix is a lovely city, but as you probably know, it gets hot. In fact, high temps can average as much as 104 degrees in the summer months. Despite the heat and the dry climate, many plants and ...

Kingsport Fire Department/Facebook A dog in Tennessee has reunited with her family after she was stranded in a tree 20 feet above ground amid Hurricane Helene flooding. On Wednesday, Oct.

1008900 Royal Central School of Speech and Drama (The) London ENGLAND Eligible 942300 Royal College of Art London ENGLAND Eligible 1233500 Royal College of Music London ENGLAND Eligible 2320500 Royal ...

up for sale, the newspaper reported, citing people familiar with the matter. WuXi Biologics is working with advisers to test interest in some of its European production facilities, FT said. Wuxi ...

Minutes later, she was no longer answering her family’s calls. One of her brothers dodged fallen trees and downed power lines to check on her later that day, and he could barely bear to tell his ...

News updates from October 4: Oil prices notch biggest daily jump in a year; UK gives Chagos islands to Mauritius on facebook (opens in a new window) News updates from October 4: Oil prices notch ...

up for sale, the newspaper reported, citing people familiar with the matter. WuXi Biologics is working with advisers to test interest in some of its European production facilities, FT said.

China's WuXi Explores Sale of Pharma Operations as US Restrictions Loom, FT Reports (Reuters) -WuXi AppTec and WuXi Biologics are planning to sell some of their operations after the Chinese ...

WuXi AppTec has put its Advanced Therapies manufacturing unit (ATU) for cell and gene therapies—with four facilities in Philadelphia—up for sale, FT reported, citing sources familiar with the matter.